Oct 28 (Reuters) - Ipsen SA IPN.PA :
* Telesta Therapeutics IPN.PA and Ipsen announce exclusive
license agreement for MCNA1 for the treatment of non-muscle
invasive bladder cancer in major ex-United States territories
* Ipsen to develop and commercialize MCNA1 in all countries
of the world, with the exception of the United States, where
Telesta is establishing commercial operations, Canada, South
Africa, Mexico, South Korea and Japan
Source text for Eikon: ID:nBw8vXKpa
Further company coverage: IPN.PA , TST.TO
(Gdynia Newsroom)